Still tougher bandages for control of drug costs. Defending yourself against regress fees
Schmidt, K.
MMW Fortschritte der Medizin 147(39): 50-51
2005
ISSN/ISBN: 1438-3276 PMID: 16245783 Document Number: 585098
Document emailed within 1 workday
Related Documents
Lee, J. 2014: Assessing drug value. Hospitals take steps to control drug costs and aid patients Modern Healthcare 44(48): 22; 24-25Erhart, P. 1980: Holding down practice costs and fees Bulletin of the American College of Surgeons 65(4): 6-7
Marshall, T.M.; Ballantine, J.T. 1988: Complaints about fees and costs for medical records and depositions Journal of the Kentucky Medical Association 86(10): 587
McCarthy, M. 2014: Drug firms cut doctors' fees for drug talks Bmj 348: G2021
2012: Costs for traditional meds static while specialty drug costs soar Managed Care 21(6): 47
Canal, C. 1995: Treatment by natural remedies as a supportive measure. Bandages and compresses as supplemental measures to drug therapy Pflege Zeitschrift 48(6): 329-331
Lindner, K.; Cramer, H.J.; Köhler, R. 1989: Do Varicosan bandages really rarely cause contact eczema? Case report of allergic contact dermatitis caused by propyl hydroxybenzoate following the use of Varicosan bandages Dermatologische Monatschrift 175(10): 655-657
Takagi, K.; Fujimura, Y. 1969: Study on dental service fees. 2. International comparison of dental service fees with special reference to findings in various types of dental service fees from the viewpoint of balanced price indices for major dental services Shika Gakuho. Dental Science Reports 69(8): 44-49
Gatty, B. 1993: Whatever happened to user fees and the FDA's promise to expedite new drug approvals? Hospital Formulary 28(7): 656 655
Rabøl, R.; Kolbye, A.; Andersen, S.Ejdrup. 2003: Drug costs in departments of internal medicine. An analysis of costs for patients and departments Ugeskrift for Laeger 165(15): 1565-1568
Schleifer, R.; Pol, L. 2017: International Guidelines on Human Rights and Drug Control: A Tool for Securing Women's Rights in Drug Control Policy Health and human rights 19(1): 253-261
Andreasen, J. 2003: Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities Ugeskrift for laeger 165(29): 2873-2876
Martz, E.W. 1992: Can we control costs? Delaware Medical Journal 64(12): 765-766
2001: Collective regress should disappear. And then testing that beams can bend MMW Fortschritte der Medizin 143(8): 45-46
Andersen, V. 1993: Drug costs Ugeskrift for Laeger 155(42): 3398-3399
Lexchin, J. 1989: Reducing drug costs New Zealand Medical Journal 102(872): 387
Jerome, D.; Laurent, C.; Catherine, B.; Didier, S.; Bertrand, C.; Muriel, R.; Joseph, M.; Olivier, Z.; Thiery, P.; Claude, C.J.an 2002: Costs of hospital management of hepatitis C virus cirrhosis in France Comparison between real costs and diagnosis related groups based costs Results of a multicentric study carried out on 267 consecutive patients in 1998 Hepatology 36(4 Part 2): 587A
Schwartz, H. 1981: Medical costs and the drug industry Medical Times 109(3): 21s-24s; 28s
Bourla, A.; Johnson, S.R. 2015: Pharma 'could have done a better job' explaining drug costs Modern Healthcare 45(50): 30-31
Von Ferber, L.; Köster, I.; Hauner, H. 1996: Direct costs of ambulatory treatment of diabetes mellitus. Comparison of observed costs with estimated costs of adherence to the treatment standard Medizinische Klinik 91(12): 802-808